MARKET PERFORMANCE

Feb 13 2026BUSINESS

Bio-Rad's Mixed Year: Growth Amid Challenges

Bio-Rad, a big name in life science research and clinical diagnostics, just shared its financial results for 2025. The year was a bit of a rollercoaster. On one hand, they saw some growth in sales, especially in their Clinical Diagnostics segment. But on the other hand, their Life Science segment to

reading time less than a minute
Feb 13 2026BUSINESS

Big Beer Wins in Tough Times

AB InBev, the world's biggest brewer, just shared some good news. They made more money than expected in the last quarter of 2025. This is a big deal because beer sales have been struggling lately. People are buying less beer. Why? Maybe because they don't have much money. Or maybe the weather has be

reading time less than a minute
Jan 27 2026CRYPTO

Ethereum's Big Bet: Why This Company Is Going All In

Joseph Chalom, the CEO of Sharplink Gaming Inc. , acknowledges Michael Saylor's influence in the crypto space. Saylor, the leader of MicroStrategy, showed how companies can invest in Bitcoin and make it work long-term. But Chalom thinks Ethereum is even better. Ethereum is special because it can do

reading time less than a minute
Jan 24 2026CRYPTO

BitGo's Bumpy Ride on the Stock Market

BitGo, a company that keeps digital money safe, recently started selling shares to the public. At first, things looked good. The price of each share went up by 25% on the first day. But then, the excitement faded, and the price dropped. By the end of the week, shares were worth less than when they f

reading time less than a minute
Jan 22 2026BUSINESS

P&G's Mixed Results: What's Behind the Numbers?

P&G, a giant in the consumer goods world, recently shared its Q2 2026 earnings. The news was a mix of ups and downs. On one hand, the company's earnings per share (EPS) hit $1. 88, which was a bit better than expected. But on the other hand, sales were slightly lower than predicted, coming in at $22

reading time less than a minute
Jan 12 2026FINANCE

Moderna's Stock Takes a Rollercoaster Ride: What's Driving the Changes?

Moderna's stock has been on a wild ride lately. It started the day on a high note but then took a nosedive. This comes as no surprise, given the overall market downturn, with big players like the Dow Jones and S&P 500 also feeling the heat. So, why is Moderna's stock taking a hit? Well, the company

reading time less than a minute
Jan 10 2026FINANCE

Netflix's Stock Slide: Is It Time to Buy or Bypass?

Netflix's stock has taken a hit recently. Since October, it's dropped about 28%. That's a big deal. But is it a good time to invest? Not everyone thinks so. Some investors say Netflix isn't cheap enough yet. Even after the drop, its price is still high compared to other companies like Disney and Am

reading time less than a minute
Jan 06 2026BUSINESS

Ford's Sales Bounce Back: A Look at the Numbers

Ford has made a comeback in the U. S. market, selling more cars in 2025 than it has in the past few years. With 2. 2 million vehicles sold, it's the best year for Ford since 2019. That's a 6% increase from the year before. Even though it's not as many as they sold in 2019, it's still a big deal. Fo

reading time less than a minute
Jan 05 2026FINANCE

Crypto Trading Takes Off Despite Market Slump

In 2025, something interesting happened in the world of crypto trading. Even though the prices of big cryptocurrencies like Bitcoin and Ethereum were going down, people were still really into trading derivatives on CME Group. This platform saw a huge jump in trading activity for crypto derivatives.

reading time less than a minute
Jan 03 2026FINANCE

A Crypto-Health Firm's Bumpy Ride: Kindly MD's Stock Takes a New Year Leap

Kindly MD, a company blending healthcare and crypto, saw its stock rise on the first trading day of 2026. This comes after a tough period, including a warning from Nasdaq about being removed from the exchange. The company, which started as a healthcare provider, merged with a crypto firm in mid-2025

reading time less than a minute